The relevance of experimental models in the pathogenetic investigation of primary IgA nephropathy

Annales de Medecine Interne

Volumn 150, Issue 2, 1999, Pages 99-107

  Montinaro, Vincenzo ^a   Gesualdo, Loreto ^a   Schena, Francesco Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Experimental models; IgA glomerulonephritis

Indexed keywords

CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL RESEARCH; COMPLEMENT ACTIVATION; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; KIDNEY FAILURE; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS INFECTION;

ANIMALS; AUTACOIDS; COMPLEMENT ACTIVATION; CYTOKINES; DIET; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS, IGA; GROWTH SUBSTANCES; HUMANS; IMMUNITY, MUCOSAL; KIDNEY FAILURE, CHRONIC; VIRUS DISEASES;

EID: 0032991226     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. BERGER J, HINGLAIS N: Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 1968; 74: 694-5.
2. RODICIO JL: Idiopathic IgA nephropathy. Kidney Int 1984; 25: 717-29.
3. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-15.
4. NICHOLLS KM, FAIRLEY KF, DOWLING JP, KINCAID-SMITH P: The clinical course of mesangial IgA associated nephropathy in adults. Q J Med 1984; 53: 227-50.
5. D'AMICO G, IMBASCIATI E, BARBIANO DI BELGIOIOSO G, BERTOLI S, FOGAZZI G, FERRARIO F, FELLIN G, RAGNI A, COLASANTI G, MINETTI L, PONTICELLI C: Idiopathic IgA mesangial nephropathy: clinical and histological study of 374 patients. Medicine 1985; 64: 49-60.
6. EMANCIPATOR SN, LAMM ME: Biology of Disease. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest 1989; 60: 168-83.
7. RIFAI A: The parallax of IgA immune complex associated nephropathy. J Nephrol 1989; 2: 127-34.
8. RIFAI A, SMALL PA, TEAGUE PO, AYOUB EM: Experimental IgA nephropathy. J Exp Med 1979; 150: 1161-73.
9. LESAVRE P, DIGEON M, BACH JF: Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 1982; 48: 61-9.
10. HALL RP, STACHURA I, CASON J, WHITESIDE TL, LAWLEY TJ: IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med 1983; 74: 56-63.
11. COPPO R, BASOLO B, PICCOLI G, MAZZUCCO G, BULZONI MR, ROCCATELLO D, DE MARCHI M, CARBONARA AO, Barbiano di Belgioioso G: IgAl and IgA2 immune complexes in primary IgA nephropathy and Henoch-Shönlein nephritis. Clin Exp Immunol 1984; 57: 583-90.
12. EGIDO J, SANCHO J, RIVERA F, HERNANDO L: The role of IgA and IgG immune complexes in IgA nephropathy. Nephron 1984; 36: 52-9.
13. VALENTIJN RM, KAUFMAN RH, BRUTEL DE LA RIVIERE G, DAHA MR, VAN Es LA: Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 1983; 74: 375-81.
14. TSAI CC, GIANGIACOMO J, ZUCKNER J: Dermal IgA deposits in Henoch-Shönlein purpura and Berger's nephritis. Lancet 1975; i: 342-3.
15. THOMPSON AJ, CHAN YL, WOODROFFE AJ, CLARKSON AR, SEYMOUR AE: Vascular IgA deposits in clinically normal skin of patients with renal disease. Pathology 1980; 12: 407-13.
16. HENE RJ, VELTHUIS P, VAN DE WEIL A, KLEPPLER D, DORHOUT MEES EJ, KATER L: The relevance of IgA deposits in vessel walls of clinical normal skin. Arch Int Med 1986; 146: 745-9.
17. MONTINARO V, AVENTAGGIATO L, CAVALLO T, RIFAI A: Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy. Nephrol Dial Transplant 1995; 10: 2035-42.
18. RIFAI A, MILLARD K: Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol 1985; 60: 363-8.
19. CHEN A, WONG SS, RIFAI A: Glomerular immune deposits in experimental IgA nephropathy: A continuum of circulating and in situ formed immune complexes. Am J Pathol 1988; 130: 216-22.
20. CHEN A, SHEU LF, DING SL, LEE WH: Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy. Lab Invest 1996; 74: 737-46.
21. CHEN A, DING SL, SHEU LF, SONG YB, SHIEH SD, SHAIO MF, CHOU WY, Ho YS: Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states. Lab Invest 1994; 70: 639-47.
22. CHEN A, SHEU LF, SHAIO MF, HUANG TH, DING SL, LEE WH: Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition. Nephron 1998; 78: 464-73.
23. VAN DEN WALL BAKE AWL, DAHA MR, HAAIJMAN JJ, RADL J, VAN DER ARK A, VAN Es LA: Elevated production of polymeric and monomeric IgA1 by bone marrow in IgA nephropathy. Kidney Int 1989; 35: 1400-4.
24. LOPEZ TRASCASA M, EGIDO J, SANCHO J, HERNANDO L: IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 1980; 42: 247-54.
25. SINICO RA, FORNASIERI A, ORENI N, BENUZZI S, D'AMICO G: Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephroapthy (Berger's disease). J Immunol 1986; 137: 536-41.
26. SCHENA FP, PASTORE A, SINICO RA, MONTINARO V, FORNASIERI A: Polymeric IgA decreases the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy. J Immunol 1988; 141: 125-30.
27. SCHENA FP, PASTORE A, MONTINARO V: The role of polymeric IgA in Complement-mediated solubilization of IgG and IgA immune complexes. Am J Kidney Dis 1988; 12: 433-6.
28. TAKAHASHI M, TACK BF, NUSSENZWEIG V: Requirements of the solubilization of immune aggregates by complement. Assembly of a factor B-dependent C3 convertase on the immune complexes. J Exp Med 1977; 145: 86-100.
29. MONTINARO V, PASTORE A, SCHENA FP: Polymeric IgA inhibits the Complement mediated Solubilization Process by reducing C3b production mediated by immune complexes (Abstract). Complement 1988; 5: 206.
30. HARPER SJ, FEEHALLY J: The pathogenetic role of immunoglobulin A polymers in immunoglobulin A nephropathy. Nephron 1993, 65: 337-45.
31. ISAACS K, MILLER F, LANE B: Experimental model for IgA nephropathy. Clin Immunol Immunopathol 1981; 20: 419-26.
32. ISAACS K, MILLER F: Role of antigen size and charge in immune complex glomerulonephritis. I. Active induction of disease with dextran and its derivatives. Lab Invest 1982; 47: 198-205.
33. ISAACS K, MILLER F: Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexes. Am J Pathol 1983; 11: 298-306.
34. GESUALDO L, RICANATI S, HASSAN MO, EMANCIPATOR SN, LAMM ME: Enzymolysis of glomerular immune deposits in vitro with dextranase/protease ameliorates proteinuria, hematruria, and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest 1990; 86: 715-22.
35. PASI A, DENDORFER U, HOLTHÖFER H, NELSON PJ, TAZZARI S, ARMELLONI S, FORNASIERI A, D'AMICO G, SCHLÖNDORFF D: Characterization of nephropathy induced by immunization with high molecular weight dextran. Nephrol Dial Transplant 1997; 12: 1849-55.
36. BURG M, GRÖNE HJ, KOCH KM, FLOEGE J: Cationic dextran induces mesangioproliferative nephritis in rats independent of IgA deposition. Nephrol Dial Transplant 1997; 12: 1856-62.
37. MONTINARO V, ESPARZA A, CAVALLO T, RIFAI A: The antigen as mediator of glomerular injury in experimental IgA nephropathy. Lab Invest 1991; 64: 508-19.
38. EMANCIPATOR SN, GALLO GR, LAMM ME: Experimental IgA nephropathy induced by oral immunization. J Exp Med 1983; 157: 572-82.
39. GENIN C, LAURENT B, SABATIER JC, COLON S, BERTHOUX SC: IgA mesangial deposits in C3H/HeJ mice after oral immunization with ferritin or bovine serum albumin. Clin Exp Immunol 1986; 63: 385-93.
40. SATO M, IDEWA T, KOSHIKOWA S: Experimental IgA nephroapthy in mice. Lab Invest 1986; 54: 377-84.
41. TRACHTMAN H, CHAN JC, CHAN W, VALDERRAMA E, BRANDT R, WAKELY P, FUTTERWEIT S, MAESAKA J, MA C: Vitamin E ameliorates renal injury in a experimental model of immunoglobulin A nephropathy. Pediatr Res 1996, 40: 620-6.
42. YI ZW, RODRIGUEZ GE, KRIEG RJ Jr, TOKIEDA K, CHAN JC: Rat macrophages in experimental IgA nephropathy. Biochem Mol Med 1996; 57: 152-5.
43. COPPO R, BASOLO B, ROLLINO C, ROCCATELLO D, MARTINA G, AMORE A, BONGIORNO G, PICCOLI G: Mediterranean diet and primary IgA nephropathy. Clin Nephrol 1986; 26: 72-82.
44. KUMAR V, SIENIAWSKA M, BEUTNER EH, CHORZELSKI TP: Are immunological markers of gluten-sensitive enteropathy detectable in IgA nephropathy? Lancet 1988; ii: 1307.
45. FORNASIERI A, SINICO RA, MALDIFASSI P, BERNASCONI P, VEGNI M, D'AMICO G: IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 1987; 295: 78-80.
46. ROSTOKER G, LAURENT J, ANDRE' C, CHOLIN S, LAGRUE G: High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet 1988; i: 356-7.
47. COPPO R, ROCCATELLO D, AMORE A, QUATTROCCHIO G, MOLINO A, GIANOGLIO B, AMOROSO A, BAJARDI P, PICCOLI G: Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 1990; 33: 72-83.
48. COPPO R, MAZZUCCO G, MARTINA G, ROCCATELLO D, AMORE A, NOVARA R, BARGONI A, RAGNI R, PICCOLI G, SENA LM: Gluten induced experimental IgA glomerulopathy. Lab Invest 1989; 60: 499-506.
49. RASOOLY L, ABOUZIED MM, BROOKS KH, PESTKA JJ: Polyspecific and autoreactive IgA secreted by hybridomas derived from Peyer's patches of vomitoxin-fed mice: characterization and possible pathogenic role in IgA nephropathy. Food Chem Toxic 1994; 32: 337-48.
50. RASOOLY L, PESTKA JJ: Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropathy in the Balb/c mouse. Food Chem Toxic 1994; 32: 329-36.
51. GREENE DM, AZCONA-OLIVERA JI, MURTHA JM, PESTKA JJ: Effects of dihydrotestosterone and estradiol on experimental IgA nephropathy induced by vomitoxin. Fundam Appl Toxicol 1995; 26: 107-16.
52. HINOSHITA F, SUZUKI Y, YOKOYAMA K, HARA S, YAMADAA, OGURA Y, HASHIMOTO H, TOMURA S, MARUMO F, UENO Y: Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol. Nephron; 1997; 75: 469-78.
53. KORENBLAT PE, ROTHBERG RM, MINDEN P, FARR RS: Immune responses of human adults after oral and parenteral exposure to bovine serum albumin. J Allergy 1968; 41: 226-33.
54. SEDWICK JD, HOLT PG: Down-regulation of immune responses to inhaled antigens: studies on the mechanism of induced suppression. Immunology 1985; 56: 635-42.
55. HOLT PG, LEIVERS S: Tolerance induction via antigen inhalation: isotype specificity and involvement of suppressor T cells. Int Arch Allergy Appl Immunol 1982; 67: 155-62.
56. GESUALDO L, LAMM ME, EMANCIPATOR SN: Defective oral tolerance promotes nephritogenesis in experiemntal IgA nephropathy induced by oral immunization. J Immunol 1990; 145: 3684-91.
57. MOWAT AM, STROBEL S, DRUMMOND HE, FERGUSON A: Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 1982; 45: 105-13.
58. STROBEL S, MOWAT AM, DRUMMOND H, PICKERING M, FERGUSSON A: Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut-processed antigen. Immunology 1983; 49: 451-6.
59. MOWAT AC, PARROT DMV: Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 1983; 50: 547-54.
60. WALDO FB, COCHRAN AM: Systemic immune response to oral polio immunization in patients with IgA nephropathy. J Clin Lab Immunol 1989; 28: 109-16.
61. LEINIKKI PO, MUSTONEN J, PASTERNACK A: Immune response to oral polio vaccine in patients with glomerulonephritis. Clin Exp Immunol 1987; 68: 33-8.
62. MARKHAM RV Jr, SUTHERLAND JC, MARDINEY MR Jr: The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest 1973; 29: 111-20.
63. IMAI H, NAKAMOTO Y, ASAKURA K, MIKI K, YASUDA T, MIURA AB: Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985; 27: 756-61.
64. WAKUI H, IMAI H, NAKAMOTO Y, KOBAYASHI R, ITOH H, MIURA AB: Anti-histone autoantibodies in ddy mice, an animal model for spontaneous IgA nephritis. Clin Immunol Immunopathol 1989; 52: 248-56.
65. KAWAGUCHI S, TANAKA H, HOSHINO K, KATSUMATA Y, MASUDA Y, ISHIZAKI M, YAMANAKA M, MASUGI Y: Suppression of glomerular IgA deposition in ddY mice through periodic injections of lipopolysaccharides. Clin Immunol Immunopathol 1988; 48: 362-70.
66. SINNIAH R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 1983; 36: 276-93.
67. VARIS J, RANTALA I, PASTERNACK A: Immunofluorescence of immunoglobulins and complement in kidneys taken at necropsy. J Clin Pathol 1989; 42: 1211-4.
68. PORTER DD, LARSEN AE. PORTER HG: Aleutian disease of mink. Adv Immunol 1980; 29: 261-6.
69. PORTIS JL, COE JE: Deposition of IgA in renal glomeruli of mink affected with Aleutian disease. Am J Pathol 1979; 96: 227-36.
70. JESSEN RH, NEDRUD JG, EMANCIPATOR SN: A mouse model of IgA nephropathy induced by Sendai virus. Adv Exp Med Biol 1987; 216: 1609-18.
71. EMANCIPATOR SN, GALLO GR, LAMM ME: IgA nephropathy: perspectives on pathogenesis and classification. Clin Nephrol 1985; 24: 161-79.
72. COUSER WG, BAKER PJ, ADLER S: Complement and the direct mediation of immune glomerular injury: A new perspective. Kidney Int 1985; 28: 879-90.
73. RIFAI A, CHEN A, IMAI H: Complement activation in experimental IgA nephropathy: an antigen-mediated process. Kidney Int 1987; 32: 838-44.
74. IMAI H, CHEN A, WYATT RJ, RIFAI A: Lack of complement activation by human IgA immune complexes. Clin Exp Immunol 1988; 73: 479-83.
75. VAN DIXHOORN MGA, GORTER A, SATO T, VAN DER WAL AM, VAN EENDENBURG JDP, ROZING J, DAHA MR, DE HEER E: Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-thy-1-1 antibody in the rat. Kidney Int 1996, 50: 1612-23.
76. SCHENA FP, PASTORE A, LUDOVICO N, SINICO RA, BENUZZIS, MONTINARO V: Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol 1989; 77: 15-20.
77. EMANCIPATOR SN, OVARY Z, LAMM ME: The role of mesangial complement in the hematuria of experimental IgA nephropathy. Lab Invest 1987; 57: 269-76.
78. TOMINO Y, YAGAME M, EGUKI K, NOMOTO Y, SAKAI H: Immunofluorescent studies on S-protein in glomeruli from patients with IgA Nephropathy. Am J Pathol 1987; 129: 402-6.
79. RAUTERBERG EW, LIEBERKNECHT HM, WINGEN AM, RITZ E: Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int 1987; 31: 820-9.
80. RIFAI A, WU CG, MONTINARO V, ESPARZA A, STRIKER L: Experimental IgA nephropathy in C5 deficient and sufficient mice (Abstract). Kidney Int 1990; 37: 429.
81. FALUS A, BEUSCHER HU, AUERBACH HS, COLTEN HR: Constitutive and IL-1-regulated murine complement gene expression is strain and tissue specific. J Immunol 1987; 138: 856-60.
82. MONTINARO V, DI CILLO M, PERISSUTTI S, SERRA L, TEDESCO F, RIFAI A, SCHENA FP: Modulation of renal production of C3 by proinflammatory cytokines. Kidney Int 1993; 43 (Suppl 39): S37-40.
83. MONTINARO V, GESUALDO L, RANIERI E, MONNO R, GRANDALIANO G, SCHENA FP: Renal cortical complement C3 gene expression in IgA nephropathy. J Am Soc Nephrol 1997; 8: 415-25.
84. NAGASAWA R, ISHII K, MARUYAMA N, MITARAI T, ISODA K: Reconstitution of SCID mouse with tonsillar cells from patients with IgA nephropathy. Acta Otolaryngol. Suppl. (Stockh) 1996; 523: 185-8.
85. MONTINARO V, HEVEY K, AVENTAGGIATO L, FADDEN K, ESPARZA AR, CHEN A, FINBLOOM DS, RIFAI A: Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 1992; 42: 341-353.
86. HORII Y, MURAGUCHI A, IWANO M, MATSUDA T, HIRAYAMA T, YAMADA H, FUJII Y, DOHI K, ISHIKAWA H, OHMOTO Y, YOSHIZAKI K, HIRANO T, KISHIMOTO T: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143: 3949-56.
87. CHEN A, SHEU LF, CHOU WY, TSAI SC, CHANG DM, LIANG SC, LIN FG, LEE WH: Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice. Am J Kid Dis 1997; 30: 693-702.
88. GESUALDO L, EMANCIPATOR SN, KESSELHEIM C, LAMM ME: Glomerular hemodynamics and eicosanoid synthesis in a rat model of IgA nephropathy. Kidney Int 1992; 42: 106-14.
89. SHUTZ PJ, DI CORLETO PE, SILVER BJ, ABBOUD HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988; 255: F674-84.
90. SILVER BJ, JAFFER FE, ABBOUD HE: Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA 1989; 86: 1056-60.
91. JOHNSON RJ, FLOEGE J, COUSER WJ, ALPERS CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1993; 4: 119-28.
92. GESUALDO L, PINZANI M, FLORIANO JJ, HASSAN MO, NAGY NU, SCHENA FP, EMANCIPATOR SN, ABBOUD HE: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 1991; 65: 160-7.
93. GESUALDO L, DI PAOLO S, MILANI S, PINZANI M, GRAPPONE C, RANIERI E, PANNARALE G, SCHENA FP: Expression of platelet-derived growth factor receptors in normal and diseased human kidney. J Clin Invest 1994; 94: 50-8.
94. HERNANDO P, GONZALEZ E, EGIDO J, DE NICOLAS R, GOSMEZ C, GOMEZ-CHIARRI M, HERNANDO L: Release of platelet activating factor and oxygen radicals by mesangial cells stimulated with IgA and IgG immune aggregates (Abstract). Nephrol Dial Transplant 1989; 4: 427.